Literature DB >> 7885351

Evidence of peripheral axonal neuropathy in primary restless legs syndrome.

S Iannaccone1, M Zucconi, P Marchettini, L Ferini-Strambi, R Nemni, A Quattrini, S Palazzi, M Lacerenza, F Formaglio, S Smirne.   

Abstract

Restless legs syndrome (RLS) is a well-defined clinical entity characterized by an unpleasant creeping sensation arising in the legs with an irresistible need to move them. The trouble is more pronounced when the affected people lie in a prolonged rest position and try to fall asleep. It is known that RLS may be consequent to systemic disorders and to diseases affecting the central or peripheral nervous system. The International Classification of Sleep Disorders states that peripheral neuropathy should be ruled out by medical history and clinical grounds before diagnosing primary RLS (pRLS). The present study extended peripheral nerve investigation in eight consecutive pRLS patients with normal neurological examination results and showed that all patients exhibited two or more electrical, psychophysiological, and/or morphological features of peripheral axonal neuropathy. Morphometric analysis of sural nerve showed a significant reduction in myelinated fiber density and g ratio (axon diameter/fiber diameter) in the pRLS group compared with eight control biopsy specimens. These results suggest that axonal neuropathy is often present in patients with RLS. A comprehensive peripheral nerve investigation should be considered in RLS patients.

Entities:  

Mesh:

Year:  1995        PMID: 7885351     DOI: 10.1002/mds.870100103

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  17 in total

Review 1.  Role of dopamine receptor agonists in the treatment of restless legs syndrome.

Authors:  Svenja Happe; Claudia Trenkwalder
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 2.  [Neurophysiological and neuroimaging studies for restless legs syndrome and periodic leg movement disorder].

Authors:  S Happe; W Paulus
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

3.  Alterations in pain responses in treated and untreated patients with restless legs syndrome: associations with sleep disruption.

Authors:  Robert R Edwards; Phillip J Quartana; Richard P Allen; Seth Greenbaum; Christopher J Earley; Michael T Smith
Journal:  Sleep Med       Date:  2011-05-12       Impact factor: 3.492

Review 4.  Disorders of pulmonary function, sleep, and the upper airway in Charcot-Marie-Tooth disease.

Authors:  Loutfi S Aboussouan; Richard A Lewis; Michael E Shy
Journal:  Lung       Date:  2007-02-09       Impact factor: 2.584

Review 5.  Restless legs syndrome.

Authors:  William G Ondo
Journal:  Curr Neurol Neurosci Rep       Date:  2005-07       Impact factor: 5.081

Review 6.  Restless legs syndrome: differential diagnosis and management with pramipexole.

Authors:  Francesca Brindani; Francesca Vitetta; Franco Gemignani
Journal:  Clin Interv Aging       Date:  2009-06-29       Impact factor: 4.458

7.  Functional Evaluation of Small Fiber Pathways in Primary Restless Legs Syndrome: Aδ Pathway Study.

Authors:  Michał Fila; Mariusz Stasiołek; Adam Markiewicz; Andrzej Bogucki
Journal:  J Clin Sleep Med       Date:  2017-12-15       Impact factor: 4.062

8.  Idiopathic restless legs syndrome: abnormalities in central somatosensory processing.

Authors:  Jörn Schattschneider; Andre Bode; Gunnar Wasner; Andreas Binder; Günther Deuschl; Ralf Baron
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

9.  Restless legs syndrome in a patient with multifocal motor neuropathy.

Authors:  Daniele Lo Coco; Emanuele Cannizzaro; Gianluca Lopez
Journal:  Neurol Sci       Date:  2009-07-02       Impact factor: 3.307

10.  Comorbidity of restless legs syndrome and HIV infection.

Authors:  S Happe; L Kundmüller; D Reichelt; I-W Husstedt; S Evers
Journal:  J Neurol       Date:  2007-10-15       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.